Unaudited Condensed Statement of Cash Flows - USD ($)	7 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Cash flows from operating activities
Net income (loss)	$ (90,190)	$ (39,607)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Interest income and dividend income earned in cash and investments income held in trust account		(632,633)
Change in operating assets and liabilities:
Decrease in prepayment		167,268
Decrease in accrued liabilities		(241,528)
Net cash used in operating activities	(90,190)	(746,500)
Cash flows from financing activities
Proceed from issuance of common stock	25,000
Advance from a related party	282,637	160,464
Payment of deferred offering costs	(217,447)
Net cash provided by financing activities	90,190	160,464
NET CHANGE IN CASH		(586,036)
Cash, beginning of period		1,365,181
Cash, end of period		779,145
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:
Accretion of carrying value to redemption value		(632,984)
Deferred offering costs paid by a related party	$ 190,000